CMPX
NASDAQ · Biotechnology
Compass Therapeutics Inc
$1.96
+0.19 (+10.73%)
Open$1.79
Previous Close$1.77
Day High$2.01
Day Low$1.75
52W High$6.88
52W Low$1.61
Volume—
Avg Volume29.21M
Market Cap325.96M
P/E Ratio—
EPS$-0.31
SectorBiotechnology
Analyst Ratings
Strong Buy
21 analysts
Price Target
+2,643.4% upside
Current
$1.96
$1.96
Target
$53.77
$53.77
$36.32
$53.77 avg
$66.75
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.15M | 182.11M | 191.80M |
| Net Income | -66,446,946 | -42,646,254 | -48,286,720 |
| Profit Margin | -5,808.8% | -23.4% | -25.2% |
| EBITDA | -75,469,235 | -49,107,977 | -55,425,546 |
| Free Cash Flow | — | -37,978,554 | -43,960,363 |
| Rev Growth | — | -8.0% | +10.9% |
| Debt/Equity | — | 0.29 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |